Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Oliver Sartor MD
Oliver Sartor MD Advisory Board
Guru Sonpavde MD
Guru P. Sonpavde MD Advisory Board
Elizabeth Smyth MD
Elizabeth Smyth MD Advisory Board
See All Experts
featured
Published in Oncology

Journal Scan / Research · December 22, 2016

Efficacy of FOLFOXIRI Plus Bevacizumab in Liver-Limited Metastatic Colorectal Cancer

European Journal of Cancer

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Axel Grothey MD

European Journal of Cancer
Efficacy of FOLFOXIRI Plus Bevacizumab in Liver-Limited Metastatic Colorectal Cancer: A Pooled Analysis of Clinical Studies by Gruppo Oncologico del Nord Ovest
Eur. J. Cancer 2016 Dec 13;[EPub Ahead of Print], C Cremolini, M Casagrande, F Loupakis, G Aprile, F Bergamo, G Masi, R Moretto R, F Pietrantonio, F Marmorino, G Zucchelli, G Tomasello, G Tonini, G Allegrini, C Granetto, L Ferrari, L Urbani, U Cillo, P Pilati, E Sensi, A Pellegrinelli, M Milione, G Fontanini, A Falcone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated